Preparing your results

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes.

BACKGROUND: Developmental, physiological and tissue engineering studies critical to the development of successful myocardial regeneration therapies require new ways to effectively visualize and isolate large numbers of fluorescently labeled, functional cardiomyocytes. METHODOLOGY/PRINCIPAL FINDINGS: Here we describe methods for the clonal expansion of engineered hESCs and make available a suite of lentiviral vectors for that combine Blasticidin, Neomycin and Puromycin resistance based drug selection of pure populations of stem cells and cardiomyocytes with ubiquitous or lineage-specific promoters that direct expression of fluorescent proteins to visualize and track cardiomyocytes and their progenitors. The phospho-glycerate kinase (PGK) promoter was used to ubiquitously direct expression of histone-2B fused eGFP and mCherry proteins to the nucleus to monitor DNA content and enable tracking of cell migration and lineage. Vectors with T/Brachyury and alpha-myosin heavy chain (alphaMHC) promoters targeted fluorescent or drug-resistance proteins to early mesoderm and cardiomyocytes. The drug selection protocol yielded 96% pure cardiomyocytes that could be cultured for over 4 months. Puromycin-selected cardiomyocytes exhibited a gene expression profile similar to that of adult human cardiomyocytes and generated force and action potentials consistent with normal fetal cardiomyocytes, documenting these parameters in hESC-derived cardiomyocytes and validating that the selected cells retained normal differentiation and function. CONCLUSION/SIGNIFICANCE: The protocols, vectors and gene expression data comprise tools to enhance cardiomyocyte production for large-scale applications.

Pubmed ID: 19352491


  • Kita-Matsuo H
  • Barcova M
  • Prigozhina N
  • Salomonis N
  • Wei K
  • Jacot JG
  • Nelson B
  • Spiering S
  • Haverslag R
  • Kim C
  • Talantova M
  • Bajpai R
  • Calzolari D
  • Terskikh A
  • McCulloch AD
  • Price JH
  • Conklin BR
  • Chen HS
  • Mercola M


PloS one

Publication Data

April 8, 2009

Associated Grants

  • Agency: NHLBI NIH HHS, Id: 5P01HL46345-12
  • Agency: NHGRI NIH HHS, Id: HG003053
  • Agency: NHLBI NIH HHS, Id: HL66621
  • Agency: NHLBI NIH HHS, Id: R33HL088266
  • Agency: NHLBI NIH HHS, Id: R37HL059502

Mesh Terms

  • Adult
  • Base Sequence
  • Cell Differentiation
  • DNA Primers
  • Drug Resistance
  • Embryonic Stem Cells
  • Fetal Proteins
  • Flow Cytometry
  • Gene Expression Profiling
  • Genetic Vectors
  • Green Fluorescent Proteins
  • Humans
  • Immunohistochemistry
  • Lentivirus
  • Myocardium
  • Promoter Regions, Genetic
  • Reverse Transcriptase Polymerase Chain Reaction
  • T-Box Domain Proteins